-
Loading metrics
EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model
-
Michael H. J. Rhodin ,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: mrhodin@enanta.com
Affiliation Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America
⨯ -
Nicole V. McAllister,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America
⨯ -
Jonathan Castillo,
Roles Data curation, Formal analysis, Investigation, Methodology, Validation
Affiliation Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America
⨯ - Sarah L. Noton,
-
Rachel Fearns,
Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Visualization
Affiliation Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America
⨯ - In Jong Kim,
- Jianming Yu,
-
Thomas P. Blaisdell,
Roles Investigation
Affiliation Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America
⨯ - Joseph Panarese,
- Brian C. Shook,
- Yat Sun Or,
- Bryan Goodwin,
- Kai Lin
https://orcid.org/0000-0003-4032-7545
EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model
- Michael H. J. Rhodin,
- Nicole V. McAllister,
- Jonathan Castillo,
- Sarah L. Noton,
- Rachel Fearns,
- In Jong Kim,
- Jianming Yu,
- Thomas P. Blaisdell,
- Joseph Panarese,
- Brian C. Shook
-
- Published: March 15, 2021
- https://doi.org/10.1371/journal.ppat.1009428